Frequent Triptan Use: Observations on Safety Issues

Headache

Volumn 44, Issue 2, 2004, Pages 178-182

  Robbins, L ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b Robbins Headache Clinic   (United States)

Author keywords

Chronic daily headache; Migraine; Triptan

Indexed keywords

ALMOTRIPTAN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ELETRIPTAN; FROVATRIPTAN; METHYSERGIDE; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; RIZATRIPTAN; SEROTONIN 1D AGONIST; SUMATRIPTAN; ZOLMITRIPTAN;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CHRONIC DAILY HEADACHE; DISEASE CLASSIFICATION; DOSE TIME EFFECT RELATION; DRUG SAFETY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; FATIGUE; FEMALE; HEADACHE; HEART MUSCLE ISCHEMIA; HUMAN; JAW DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTIDRUG RESISTANCE; NECK PAIN; PARESTHESIA; PRIORITY JOURNAL; REBOUND; RETROSPECTIVE STUDY; SELF MEDICATION; TABLET; THORAX PAIN; TREATMENT WITHDRAWAL;

ADULT; AGED; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; RETROSPECTIVE STUDIES; SELF MEDICATION; SEROTONIN AGONISTS;

EID: 1242343807     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2004.04037.x     Document Type: Article

References (17)

1. Robbins L, Maides J. Efficacy of preventive medications for chronic daily headache. Am J Pain Manage. 1999;9:130-133.
2. Robbins L. Tension headache preventive medication. In: Robbins L, ed. Management of Headache and Headache Medications. 2nd ed. New York: Springer; 2000:109-113.
3. Robbins L. Daily opioids (methadone) for refractory chronic daily headache. Headache Q. 1996;7:39-42.
4. Diamond S. Tension-type headaches. In: Dalessio DJ, Silberstein SD, eds. Wolff's Headache and Other Head Pain. 6th ed. New York: Oxford University Press; 1993:249.
5. Gokani T, Robbins L. Botulinum toxin: efficacy in migraine, tension-type and cluster headache. Am J Pain Manage. 2002;12:98-103.
6. Robbins L, Maides J. Long-term daily triptan use: 59 patients. Headache Q. 2000;11:275-277.
7. Rapoport AM, Bigal ME, Volcy M, Sheftell FD, Feleppa M, Tepper SJ. Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases. Headache. 2003;43:482-489.
8. Sheftell FD, Rapoport AM, Coddon DR. Naratriptan in the prophylaxis of transformed migraine. Headache. 1999;39:506-510.
9. Silberstein SD, Lipton SR, Solomon S, Mathew NT. Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache. 1994;34:17.
10. Lloyd K. The clinical profile of sumatriptan: safety and tolerability. Eur Neurol. 1994;34(suppl 2):40-43.
11. Visser WH, de Vriend RH, Jaspers MW, Ferrari MD. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology. 1996;47:46-51.
12. 1B/1D agonists - is there cause for concern? Cephalalgia. 1998;18:539-545.
13. Stricker BH, Ottervanger JP. Chest pain due to sumatriptan (see comments). Ned Tijdschr Geneeskd. 1992;136:1774-1776.
14. Smith T. Cardiovascular and safety concerns in using triptans in migraine patients. Headache Q. 2001;12(suppl 1):25-28.
15. Hillis WS, Macintrye PD. Sumatriptan and chest pain [letter, comment]. Lancet. 1993;342:683.
16. 1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan. Cephalalgia. 1998;18:546-551.
17. Mathew NT, Kurman R, Perez F. Drug induced refractory headache - clinical features and management. Headache. 1990;30:634-638.